淋球菌对头孢菌素类药物的敏感性-夏威夷，2003 年至 2011 年。
Gonococcal susceptibility to cephalosporins--Hawaii, 2003 to 2011.
机构信息
Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
出版信息
Sex Transm Dis. 2013 Sep;40(9):756-9. doi: 10.1097/01.olq.0000431357.18959.30.
Abstract
Among gonococcal isolates examined at the Hawaii State Laboratory Division from 2003 to 2011, the prevalence of elevated cefixime minimum inhibitory concentrations (MICs; ≥0.064 μg/mL) and elevated cefpodoxime MICs (≥0.19 μg/mL) increased over time. In contrast, few isolates exhibited elevated ceftriaxone MICs (≥0.094 μg/mL), and the prevalence of elevated ceftriaxone MICs did not change.
摘要
在 2003 年至 2011 年期间，夏威夷州立实验室分部检测的淋球菌分离株中，头孢克肟最小抑菌浓度（MIC；≥0.064μg/mL）和头孢泊肟 MIC 升高的流行率呈上升趋势。相比之下，很少有分离株表现出头孢曲松 MIC 升高（≥0.094μg/mL），且头孢曲松 MIC 升高的流行率没有变化。
相似文献
1
Gonococcal susceptibility to cephalosporins--Hawaii, 2003 to 2011.淋球菌对头孢菌素类药物的敏感性-夏威夷，2003 年至 2011 年。
Sex Transm Dis. 2013 Sep;40(9):756-9. doi: 10.1097/01.olq.0000431357.18959.30.
2
Cephalosporin susceptibility among Neisseria gonorrhoeae isolates--United States, 2000-2010.淋病奈瑟菌分离株的头孢菌素药敏性——美国，2000-2010 年。
MMWR Morb Mortal Wkly Rep. 2011 Jul 8;60(26):873-7.
3
Decreased susceptibility of Neisseria gonorrhoeae isolates from Switzerland to Cefixime and Ceftriaxone: antimicrobial susceptibility data from 1990 and 2000 to 2012.瑞士淋病奈瑟菌分离株对头孢克肟和头孢曲松的敏感性降低：1990 年至 2000 年至 2012 年的抗菌药物敏感性数据。
BMC Infect Dis. 2013 Dec 26;13:603. doi: 10.1186/1471-2334-13-603.
4
Changes in the six most common sequence types of Neisseria gonorrhoeae, including ST4378, identified by surveillance of antimicrobial resistance in northern Taiwan from 2006 to 2013.2006 年至 2013 年台湾北部地区抗菌药物耐药性监测发现淋病奈瑟菌六种主要流行株（包括 ST4378）的变化。
J Microbiol Immunol Infect. 2016 Oct;49(5):708-716. doi: 10.1016/j.jmii.2014.08.016. Epub 2014 Nov 1.
5
Neisseria gonorrhoeae multiantigen sequence typing is beneficial in further characterizing gonococcal populations in Alberta, Canada.淋病奈瑟菌多抗原序列分型有利于进一步描述加拿大艾伯塔省的淋球菌种群。
Sex Transm Dis. 2013 Sep;40(9):744-50. doi: 10.1097/01.olq.0000431356.80840.d4.
6
Cefpodoxime 10 μg disc screening test for detection of Neisseria gonorrhoeae with mosaic PBP2 and decreased susceptibility to extended-spectrum cephalosporins for public health purposes.以公共卫生为目的，使用含有 mosaic PBP2 的淋病奈瑟菌 10μg 头孢泊肟纸片筛选试验检测和对扩展谱头孢菌素敏感性降低的淋病奈瑟菌。
APMIS. 2011 Jun;119(6):356-63. doi: 10.1111/j.1600-0463.2011.02729.x. Epub 2011 Feb 24.
7
Decreased susceptibility to cephalosporins among gonococci: data from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) in England and Wales, 2007-2011.淋病奈瑟菌对头孢菌素类药物的敏感性降低：来自 2007-2011 年英格兰和威尔士淋球菌对抗微生物药物耐药性监测计划（GRASP）的数据。
Lancet Infect Dis. 2013 Sep;13(9):762-8. doi: 10.1016/S1473-3099(13)70143-9. Epub 2013 Jun 11.
8
Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.淋病奈瑟菌抗菌药物敏感性监测 - 淋球菌分离株监测项目，美国 27 个监测点，2014 年。
MMWR Surveill Summ. 2016 Jul 15;65(7):1-19. doi: 10.15585/mmwr.ss6507a1.
9
Significant increase in azithromycin "resistance" and susceptibility to ceftriaxone and cefixime in Neisseria gonorrhoeae isolates in 26 European countries, 2019.2019 年，26 个欧洲国家淋病奈瑟菌分离株中阿奇霉素“耐药性”和头孢曲松及头孢克肟敏感性显著增加。
BMC Infect Dis. 2022 Jun 7;22(1):524. doi: 10.1186/s12879-022-07509-w.
10
Emergence and Spread of Neisseria gonorrhoeae Isolates With Decreased Susceptibility to Extended-Spectrum Cephalosporins in Argentina, 2009 to 2013.2009年至2013年阿根廷对超广谱头孢菌素敏感性降低的淋病奈瑟菌分离株的出现与传播
Sex Transm Dis. 2017 Jun;44(6):351-355. doi: 10.1097/OLQ.0000000000000603.
引用本文的文献
1
Assessing the National Representativeness of Estimates of Antimicrobial-Resistant Urogenital Neisseria gonorrhoeae in US Men, Gonococcal Isolate Surveillance Project, 2008-2018.评估美国男性中耐抗生素泌尿生殖道淋病奈瑟菌估计值的全国代表性：2008-2018 年淋球菌分离监测项目。
Sex Transm Dis. 2023 Apr 1;50(4):196-202. doi: 10.1097/OLQ.0000000000001755. Epub 2022 Dec 13.
2
Emerging Trends in Antibiotic Resistant Neisseria gonorrhoeae: A National and Hawai'i Perspective.抗生素耐药淋病奈瑟菌的新趋势：美国全国及夏威夷视角
Hawaii J Health Soc Welf. 2020 Mar 1;79(3):68-70.
3
Antimicrobial Resistance in Neisseria gonorrhoeae: Proceedings of the STAR Sexually Transmitted Infection-Clinical Trial Group Programmatic Meeting.淋病奈瑟菌的耐药性：STAR 性传播感染临床研究组计划会议记录。
Sex Transm Dis. 2019 Mar;46(3):e18-e25. doi: 10.1097/OLQ.0000000000000929.
4
Cluster of Neisseria gonorrhoeae Isolates With High-level Azithromycin Resistance and Decreased Ceftriaxone Susceptibility, Hawaii, 2016.2016年，夏威夷出现具有高水平阿奇霉素耐药性且头孢曲松敏感性降低的淋病奈瑟菌分离株群。
Clin Infect Dis. 2017 Sep 15;65(6):918-923. doi: 10.1093/cid/cix485.
5
Insights in Public Health: Leveraging Pacific Laboratories to Boost Global Health Security.公共卫生洞察：利用太平洋实验室提升全球卫生安全。
Hawaii J Med Public Health. 2016 Dec;75(12):389-392.
6
Trends in Neisseria gonorrhoeae Susceptibility to Cephalosporins in the United States, 2006-2014.2006 - 2014年美国淋病奈瑟菌对头孢菌素的敏感性趋势
JAMA. 2015 Nov 3;314(17):1869-71. doi: 10.1001/jama.2015.10347.
本文引用的文献
1
Update to CDC's Sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections.美国疾病预防控制中心性传播疾病治疗指南更新，2010 年：口服头孢菌素不再作为淋球菌感染的推荐治疗方法。
MMWR Morb Mortal Wkly Rep. 2012 Aug 10;61(31):590-4.
2
Neisseria gonorrhoeae with high-level resistance to azithromycin: case report of the first isolate identified in the United States.耐阿奇霉素淋病奈瑟菌高水平耐药：美国首例分离株报告。
Clin Infect Dis. 2012 Mar;54(6):841-3. doi: 10.1093/cid/cir929. Epub 2011 Dec 19.
3
Gonococcal resistance: are cephalosporins next?淋球菌耐药性：头孢菌素类药物会是下一个吗？
Curr Infect Dis Rep. 2011 Apr;13(2):196-204. doi: 10.1007/s11908-011-0169-9.
4
Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections.美国疾病控制与预防中心《2006年性传播疾病治疗指南》更新内容：不再推荐使用氟喹诺酮类药物治疗淋球菌感染。
MMWR Morb Mortal Wkly Rep. 2007 Apr 13;56(14):332-6.
5
Remarkable increase in central Japan in 2001-2002 of Neisseria gonorrhoeae isolates with decreased susceptibility to penicillin, tetracycline, oral cephalosporins, and fluoroquinolones.2001年至2002年期间，日本中部地区淋病奈瑟菌分离株对青霉素、四环素、口服头孢菌素和氟喹诺酮类药物的敏感性下降情况显著增加。
Antimicrob Agents Chemother. 2004 Aug;48(8):3185-7. doi: 10.1128/AAC.48.8.3185-3187.2004.
6
Multidrug-resistant Neisseria gonorrhoeae with decreased susceptibility to cefixime-Hawaii, 2001.2001年，对头孢克肟敏感性降低的多重耐药淋病奈瑟菌——夏威夷
Clin Infect Dis. 2003 Sep 15;37(6):849-52. doi: 10.1086/377500. Epub 2003 Aug 28.
7
A remarkable reduction in the susceptibility of Neisseria gonorrhoeae isolates to cephems and the selection of antibiotic regimens for the single-dose treatment of gonococcal infection in Japan.
J Infect Chemother. 2002 Mar;8(1):81-6. doi: 10.1007/s101560200011.
8
Infections due to penicillinase-producing Neisseria gonorrhoeae in the United States: 1976-1980.1976 - 1980年美国产青霉素酶淋病奈瑟菌感染情况
J Infect Dis. 1981 Aug;144(2):191-7. doi: 10.1093/infdis/144.2.191.
9
Epidemiology and treatment of penicillinase-producing Neisseria gonorrhoeae.产青霉素酶淋病奈瑟菌的流行病学与治疗
Sex Transm Dis. 1979 Apr-Jun;6(2 Suppl):152-8. doi: 10.1097/00007435-197904000-00021.
Zotero 插件